IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mymd Pharmaceuticals Inc

CUSIP: 62856X102 | 98 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

St. Johns Investment Management Company, LLC18
0.0% of portfolio›$43
StyleTurnoverLocationFiled
St. Johns Investment Management Company, LLC
18$430.0%CoreVery LowJacksonville, FL2024-04-15